Magdalena E. Sobieszczyk

Infectious Disease

180 Fort Washington Ave
New York, NY 10032

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 157 publications

Standard Risk-Based Screening Tools Fail to Reliably Predict STI Acquisition Among Persons Using PrEP in New York City: Implications for Universal STI Screening in PrEP Care.

Standard Risk-Based Screening Tools Fail to Reliably Predict STI Acquisition Among Persons Using PrEP in New York City: Implications for Universal STI Screening in PrEP Care.

Journal: Sexually transmitted diseases

Published: August 21, 2026

A phase 1 randomized controlled trial to evaluate the safety and immunogenicity of a HIV monomeric gp120 protein B-cell lineage targeting HIV vaccine in healthy adults.

A phase 1 randomized controlled trial to evaluate the safety and immunogenicity of a HIV monomeric gp120 protein B-cell lineage targeting HIV vaccine in healthy adults.

Journal: medRxiv : the preprint server for health sciences

Published: June 05, 2026

Food insecurity in New York City college students during the COVID-19 pandemic: a longitudinal analysis of predictors, correlates, and trajectories.

Food insecurity in New York City college students during the COVID-19 pandemic: a longitudinal analysis of predictors, correlates, and trajectories.

Journal: Journal of American college health : J of ACH

Published: May 31, 2026

Impact of prior SARS-CoV-2 acquisition on binding and neutralizing antibody responses following COVID-19 vaccination: A cross-protocol analysis of individual-level data from six phase 3 clinical trials.

Impact of prior SARS-CoV-2 acquisition on binding and neutralizing antibody responses following COVID-19 vaccination: A cross-protocol analysis of individual-level data from six phase 3 clinical trials.

Journal: Vaccine

Published: December 11, 2025

Bispecific 10E8.4/iMab broadly neutralizing antibody in people with or without HIV-1: a partially randomized phase 1 trial.

Bispecific 10E8.4/iMab broadly neutralizing antibody in people with or without HIV-1: a partially randomized phase 1 trial.

Journal: Nature medicine

Published: October 29, 2025

Association between COVID-19 vaccine efficacy and epidemic force of infection.

Association between COVID-19 vaccine efficacy and epidemic force of infection.

Journal: NPJ vaccines

Published: September 12, 2025

Implementation of Doxy-PEP in a Diverse Sexual Health Program in Northern Manhattan: The Doxy-Care Study.

Implementation of Doxy-PEP in a Diverse Sexual Health Program in Northern Manhattan: The Doxy-Care Study.

Journal: American journal of public health

Published: August 14, 2025

Vaccination with mRNA-encoded membrane-anchored HIV envelope trimers elicited tier 2 neutralizing antibodies in a phase 1 clinical trial.

Vaccination with mRNA-encoded membrane-anchored HIV envelope trimers elicited tier 2 neutralizing antibodies in a phase 1 clinical trial.

Journal: Science translational medicine

Published: July 30, 2025

Is Doxy-PEP Right for Me? Piloting a Novel Patient Decision Aid in an Urban Ambulatory Clinic.

Is Doxy-PEP Right for Me? Piloting a Novel Patient Decision Aid in an Urban Ambulatory Clinic.

Journal: AIDS and behavior

Published: July 12, 2025

Evaluating the Test-Negative Design for COVID-19 Vaccine Effectiveness Using Randomized Trial Data: A Secondary Cross-Protocol Analysis of 5 Randomized Clinical Trials.

Evaluating the Test-Negative Design for COVID-19 Vaccine Effectiveness Using Randomized Trial Data: A Secondary Cross-Protocol Analysis of 5 Randomized Clinical Trials.

Journal: JAMA network open

Published: May 28, 2025

High Frequency of Chronic Urticaria Following an Investigational HIV-1 BG505 MD39.3 Trimer mRNA Vaccine in a Phase 1, Randomized, Open-Label Clinical Trial (HVTN 302).

High Frequency of Chronic Urticaria Following an Investigational HIV-1 BG505 MD39.3 Trimer mRNA Vaccine in a Phase 1, Randomized, Open-Label Clinical Trial (HVTN 302).

Journal: Annals of internal medicine

Published: April 28, 2025

Overlapping Clinical Presentation of Long COVID and Postacute COVID-19 Vaccination Syndrome: Phenotypes, Severity, and Biomarkers.

Overlapping Clinical Presentation of Long COVID and Postacute COVID-19 Vaccination Syndrome: Phenotypes, Severity, and Biomarkers.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: April 15, 2025

Showing 1-12 of 157

Last Updated: 09/26/2026